Share class: Themis Medicare Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A192,100,00022,138,433 ( 24.04 %) 0 24.04 %

Major shareholders: Themis Medicare Limited

NameStocks%Valuation
Vividhmargi Investments Pvt Ltd.
26.52 %
24,429,460 26.52 % 28 M ₹
10.54 %
9,709,570 10.54 % 11 M ₹
GEDEON RICHTER INVESTMENT MANAGEMENT LTD
9.602 %
8,843,080 9.602 % 10 M ₹
7.249 %
6,676,640 7.249 % 8 M ₹
5.99 %
5,516,550 5.99 % 6 M ₹
4.034 %
3,714,910 4.034 % 4 M ₹
3.8 %
3,500,000 3.8 % 4 M ₹
2.113 %
1,945,964 2.113 % 2 M ₹
Za Capital Services India Pvt Ltd.
1.533 %
1,411,893 1.533 % 2 M ₹
1.278 %
1,176,890 1.278 % 1 M ₹
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Others38.27%
Individuals36.28%
Governments0.34%
Unknown25.11%

Based on 1000 largest holdings

Geographical origin of shareholders

India
38.6%
Individuals
36.28%

Based on 1000 largest holdings

Logo Themis Medicare Limited
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.
Employees
1,702
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!